{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:59:56Z","timestamp":1770350396443,"version":"3.49.0"},"reference-count":25,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Pulmonary hypertension (PH) is a multifactorial, progressive disease with poor outcomes. Group 2 PH is defined by pulmonary vascular disease with elevated pulmonary capillary wedge pressure including both left-sided obstructive lesions and diastolic heart failure (HF). Sildenafil was historically discouraged in this population as pulmonary vasodilation can lead to pulmonary edema. However, evidence suggests that sildenafil can help to treat the precapillary component of PH. This is a single center, retrospective pilot study of pediatric PH patients with left-sided HF who were treated with sildenafil for \u2265 4 weeks. HF patients without mechanical support (HF group) and HF patients with a left ventricular assist device (HF-VAD) were analyzed. The exploratory analysis described the safety and side effects of the drug. Echocardiographic parameters were compared before and after sildenafil treatment in a paired analysis. The changes in medical therapy during treatment, mechanical support, and mortality was reported; 19\/22 patients tolerated sildenafil. Pulmonary edema in two patients resolved upon discontinuation of sildenafil. In the HF group, both the right atrial volume and right ventricular diastolic area decreased, and the tricuspid regurgitation (TR) S\/D ratio decreased after therapy (p = 0.02). Across both the groups, four patients weaned off milrinone and seven weaned off inhaled nitric oxide. Of the thirteen HF patients, four received a transplant, and all of the nine HF-VAD patients received a transplant. Sildenafil can be safely used in carefully selected patients with HF and mixed pre\/postcapillary PH with judicious titration and inpatient surveillance, with patients showing improvements in echocardiographic parameters.<\/jats:p>","DOI":"10.3390\/children10020270","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T02:52:02Z","timestamp":1675219922000},"page":"270","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Safety and Efficacy of Sildenafil for Group 2 Pulmonary Hypertension in Left Heart Failure"],"prefix":"10.3390","volume":"10","author":[{"given":"Kinjal","family":"Desai","sequence":"first","affiliation":[{"name":"Division of Pediatric Cardiology, New York Presbyterian Morgan Stanley Children\u2019s Hospital, New York, NY 10032, USA"},{"name":"Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Di Lorenzo","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology, New York Presbyterian Morgan Stanley Children\u2019s Hospital, New York, NY 10032, USA"},{"name":"Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3856-7726","authenticated-orcid":false,"given":"Warren A.","family":"Zuckerman","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology, New York Presbyterian Morgan Stanley Children\u2019s Hospital, New York, NY 10032, USA"},{"name":"Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezinne","family":"Emeruwa","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology, New York Presbyterian Morgan Stanley Children\u2019s Hospital, New York, NY 10032, USA"},{"name":"Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5733-6096","authenticated-orcid":false,"given":"Usha S.","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology, New York Presbyterian Morgan Stanley Children\u2019s Hospital, New York, NY 10032, USA"},{"name":"Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2017.03.575","article-title":"Pulmonary Hypertension in Infants, Children, and Young Adults","volume":"69","author":"Hansmann","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1801916","DOI":"10.1183\/13993003.01916-2018","article-title":"Paediatric pulmonary arterial hypertension: Updates on definition, classification, diagnostics and management","volume":"53","author":"Rosenzweig","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jacc.2013.10.028","article-title":"Pediatric Pulmonary Hypertension","volume":"62","author":"Ivy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.healun.2019.06.022","article-title":"2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT","volume":"38","author":"Hansmann","year":"2019","journal-title":"J. Heart Lung Transplant."},{"key":"ref_6","first-page":"577","article-title":"Effect of sildenafil on pulmonary hypertension associated with left heart failure","volume":"32","author":"Wu","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.amjcard.2004.07.157","article-title":"Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure","volume":"94","author":"Alaeddini","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.transproceed.2005.02.013","article-title":"Use of oral sildenafil in patients with irreversible pulmonary hypertension not eligible for heart transplantation","volume":"37","author":"Lage","year":"2005","journal-title":"Transplant. Proc."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Meinel, K., Koestenberger, M., Sallmon, H., Hansmann, G., and Pieles, G.E. (2020). Echocardiography for the Assessment of Pulmonary Hypertension and Congenital Heart Disease in the Young. Diagnostics, 11.","DOI":"10.3390\/diagnostics11010049"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.15557\/JoU.2014.0033","article-title":"Right ventricular function assessment using tissue Doppler imaging and speckle tracking echocardiography","volume":"14","author":"Pietrzak","year":"2014","journal-title":"J. Ultrason."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0002-9149(00)01047-X","article-title":"Usefulness of the myocardial performance index for assessing right ventricular function in congenital heart disease","volume":"86","author":"Eidem","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.echo.2005.07.010","article-title":"Use of myocardial performance index in pediatric patients with idiopathic pulmonary arterial hypertension","volume":"19","author":"Dyer","year":"2006","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_13","first-page":"38","article-title":"Accuracy of quantitative echocardiographic measures of right ventricular function as compared to cardiovascular magnetic resonance","volume":"12","author":"Stedman","year":"2016","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.rmed.2015.09.003","article-title":"Right ventricular diastolic function and exercise capacity in COPD","volume":"109","author":"Fenster","year":"2015","journal-title":"Respir. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/echo.13171","article-title":"Left Ventricular End-Systolic Eccentricity Index for Assessment of Pulmonary Hypertension in Infants","volume":"33","author":"Abraham","year":"2016","journal-title":"Echocardiography"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kaski, J.C., and Kjeldsen, K.P. (2019). The ESC Handbook on Cardiovascular Pharmacotherapy, OUP Oxford.","DOI":"10.1093\/med\/9780198759935.001.0001"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5114\/aoms.2017.68938","article-title":"Pulmonary hypertension in left heart disease","volume":"15","author":"Mehra","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpeds.2018.09.067","article-title":"Sildenafil Use in Children with Pulmonary Hypertension","volume":"205","author":"Cohen","year":"2019","journal-title":"J. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/0253-7613.132158","article-title":"Effect of preoperative oral sildenafil on severe pulmonary artery hypertension in patients undergoing mitral valve replacement","volume":"46","author":"Shastri","year":"2014","journal-title":"Indian J. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1161\/CIRCULATIONAHA.111.081125","article-title":"Effects of Phosphodiesterase Type 5 Inhibition on Systemic and Pulmonary Hemodynamics and Ventricular Function in Patients with Severe Symptomatic Aortic Stenosis","volume":"125","author":"Lindman","year":"2012","journal-title":"Circulation"},{"key":"ref_21","first-page":"CD012621","article-title":"Phosphodiesterase 5 inhibitors for pulmonary hypertension","volume":"1","author":"Barnes","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.14740\/jocmr3008w","article-title":"Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients with Heart Failure with Reduced Left Ventricular Ejection Fraction: A Meta-Analysis","volume":"9","author":"Cesaro","year":"2017","journal-title":"J. Clin. Med. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.amjcard.2010.03.048","article-title":"Usefulness of the right ventricular systolic to diastolic duration ratio to predict functional capacity and survival in children with pulmonary arterial hypertension","volume":"106","author":"Alkon","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s40064-015-1317-8","article-title":"Sildenafil treatment attenuates ventricular remodeling in an experimental model of aortic regurgitation","volume":"4","author":"Eskesen","year":"2015","journal-title":"Springerplus"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/aps.2016.13","article-title":"Sildenafil ameliorates left ventricular T-tubule remodeling in a pressure overload-induced murine heart failure model","volume":"37","author":"Huang","year":"2016","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/10\/2\/270\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:19:34Z","timestamp":1760120374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/10\/2\/270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["children10020270"],"URL":"https:\/\/doi.org\/10.3390\/children10020270","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]}}}